General form of registration statement for all companies including face-amount certificate companies

STOCKHOLDERS' EQUITY (Tables)

v3.24.4
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
STOCKHOLDERS' EQUITY    
Summary of outstanding warrants to purchase common stock

The following table summarizes information with regard to outstanding warrants to purchase stock as of September 30, 2024:

Number of Common

Shares Issuable

 

Upon Exercise of

 

Outstanding

Exercise

 

Offering

    

Warrants

    

Price

    

Expiration Date

2024 Tranche A Warrants

6,739,918

$

2.52

July 21, 2029

2024 Tranche B Warrants

8,214,278

$

4.00

July 21, 2029

2024 Tranche C Warrants

4,267,152

$

5.50

July 21, 2029

2023 Tranche B Preferred Warrants

439,560

$

4.7775

September 8, 2028

2022 Common Warrants

4,201,044

$

1.96

October 25, 2027

June 2020 Series H Common Warrants

720,796

$

12.075

June 5, 2025

October 2017 Series D Common Warrants

31,085

$

178.00

 

October 14, 2024

Total

 

24,613,833

 

  

 

  

The following table summarizes the outstanding warrants to purchase stock as of December 31, 2023:

Number of

Shares Issuable

Upon

Exercise of

Outstanding

Exercise

Offering

    

Warrants

    

Price

    

Expiration Date

2023 Tranche A Preferred Warrants

13,846,154

$

3.185

September 8, 2026

(1)

2023 Tranche B Preferred Warrants

7,179,487

$

4.7775

September 8, 2028

(1)

2022 Common Warrants

 

4,748,221

$

1.96

October 25, 2027

(2)

2022 Pre-Funded Common Warrants

 

1,079,136

$

0.00001

N/A

(2)

June 2020 Series H Common Warrants

720,796

$

12.075

June 5, 2025

May 2019 Series F Common Warrants

195,700

$

24.00

May 20, 2024

May 2019 Series G Common Warrants

201,800

$

24.00

May 20, 2024

October 2017 Series D Common Warrants

 

31,085

$

178.00

October 14, 2024

Total

 

28,002,379

 

  

  

(1) These warrants are described further under the caption “September 2023 Private Placement” above.
(2) These warrants are described further under the caption “October 2022 Public Offering and Private Placement” above.